Insider Selling: Dr. Martens (LON:DOCS) Insider Sells 105,785 Shares of Stock

Key Points

• Insider Giles Wilson sold 105,785 shares of Dr. Martens stock at an average price of GBP 90, totaling £95,206.50.
• Wilson made additional purchases of Dr. Martens stock recently, including 30,019 shares at GBP 91 just before the sale.
• Dr. Martens shares opened at GBP 90.23 with a market capitalization of £871.28 million and a price-to-earnings ratio of 18,046.80.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson sold 105,785 shares of the stock in a transaction that occurred on Monday, September 1st. The shares were sold at an average price of GBX 90, for a total value of £95,206.50.

Giles Wilson also recently made the following trade(s):

• On Monday, September 1st, Giles Wilson purchased 105,838 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 91 per share, for a total transaction of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total transaction of £27,300.
• On Monday, September 1st, Giles Wilson purchased 30,019 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 91 per share, for a total transaction of £27,317.29.
• On Monday, August 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 77 per share, for a total transaction of £149.38.
• On Friday, July 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were bought at an average price of GBX 77 per share, for a total transaction of £149.38.
• On Wednesday, June 11th, Giles Wilson purchased 189 shares of Dr. Martens stock. The shares were bought at an average price of GBX 79 per share, for a total transaction of £149.31.

Dr. Martens Trading Up 1.8%

Shares of LON DOCS traded up GBX 1.60 during trading on Friday, hitting GBX 92.05. 54,296,586 shares of the company were exchanged, compared to its average volume of 2,190,337. Dr. Martens plc has a 12-month low of GBX 43.02 and a 12-month high of GBX 94.35. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a fifty day moving average price of GBX 81.64 and a 200-day moving average price of GBX 67.13. The firm has a market capitalization of £888.82 million, a PE ratio of 18,410.00, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on DOCS shares. Peel Hunt upgraded Dr. Martens to a "buy" rating in a report on Monday, August 18th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a research report on Friday, July 11th. Finally, Royal Bank Of Canada cut their price objective on Dr. Martens from GBX 7,000 to GBX 6,000 and set a "sector perform" rating for the company in a research report on Monday, May 19th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of GBX 6,000.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.